ReviewMedical gas research2027
Experimental evidence for the beneficial effects of low-concentration ozone.
Review in Medical gas research, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ozone (O3), a molecule consisting of three oxygen atoms, is an unstable compound whose clinical application as a complementary therapy continues to expand. Although numerous clinical studies support its therapeutic potential, the molecular basis of its effects has remained poorly understood. This review summarizes the current knowledge on the cellular and molecular mechanisms activated by low-concentration O3. Central to its action is the induction of mild oxidative stress by low concentrations of O3, which triggers an antioxidant response mediated through nuclear factor erythroid 2-related factor 2, enhancing cell survival. Additionally, low-concentration O3 exhibits antiinflammatory properties by modulating cytokine expression, inhibiting metalloproteinases, and activating macrophages. The regenerative potential of low-concentration O3 may be attributed to the stimulation of fibroblasts, chondrocytes, and osteoblasts. Moreover, the antitumor effects of low-concentration O3 in cancer cell lines and animal models appear to be linked to the inhibition of cell proliferation and migration, as well as proapoptotic activity. More research is needed to determine the best treatment methods, long-term effectiveness, and standardized clinical procedures for ozone therapy in specific diseases. This review provides a detailed reference for understanding how O3 therapy works.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.